Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells
Publication in refereed journal

Times Cited
Web of Science31WOS source URL (as at 16/07/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractRecent studies have suggested the inhibition of cyclooxygenase-2 (COX-2) as strategy to prevent colorectal cancer. In this study, the cytostatic and cytotoxic effects of different non-steroidal anti-inflammatory drugs (NSAIDs), all of them are reported COX inhibitors, were investigated in human skin melanoma A-375 cells. Using BrdU-ceII proliferation assay, we showed that 50 and 100 mu M of celecoxib (CEL) reduced proliferation of the melanoma cells at 72-h incubations by 34.0% and 82.7%, respectively. As determined by Toxilight((TM))-cytotoxicity assay, the drug was only toxic to the cancer cells at 100 mu M. Indomethacin (IND) also inhibited the cell proliferation by about 40% at 240 and 480 PM and was only slightly toxic to the melanoma. Neither aspirin (ASP) nor piroxicam (PIR) exhibited cytostatic or cytotoxic effect on the cancer cells. Combinatory effects of the above NSAIDs with dietary docosahexaenoic acid (DHA) on inhibiting growth of the melanoma cells were further elucidated. Each of the NSAIDs, at doses 10-480 mu M, was incubated simultaneously with the melanoma cells and 160 pM of DHA for 72 h. Results from MTT assay showed that both CEL and IND, starting from 20 pM, exhibited additive effects on the DHA-induced growth inhibition. ASP also enhanced the DHA-induced growth inhibition by 42.8% at 480 pM. To our surprise, although PRX did not suppress the melanoma growth, the drug at 40-240 pM enhanced the DHA-induced growth inhibition by 15.9-66.4%, respectively. Results from these studies suggest that the anticancer effects of NSAIDs may not be explained solely by their COX-inhibitory activities. Further studies are therefore required to understand their modes of action, before they could be used alone or in combinations with other agents for cancer chemoprevention. (c) 2005 Elsevier SAS. All rights reserved.
All Author(s) ListChiu LCM, Tong KF, Ooi VEC
Name of Conference1st Annual Conference of the Organization-for-Oncology-and-Transitional-Research
Start Date of Conference15/10/2004
End Date of Conference16/10/2004
Place of ConferenceHong Kong
Journal nameBiomedicine and Pharmacotherapy
Volume Number59
PagesS293 - S297
LanguagesEnglish-United Kingdom
Keywordsdocosahexaenoic acid; melanoma; non-steroidal anti-inflammatory drugs
Web of Science Subject CategoriesMedicine, Research & Experimental; MEDICINE, RESEARCH & EXPERIMENTAL; Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY; Research & Experimental Medicine

Last updated on 2020-16-07 at 23:18